Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,208.2
16.0 (0.50%)

 

  • STI Straits Times Index
    3,208.2
    16.0 (0.50%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.3
    -0.9 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,617.9
    151.0 (0.57%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,913.8
    10.2 (0.35%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,206.0
    167.4 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,117.4
    -
    Index delayed 10 minutes
  • KOR KOSPI
    2,103.6
    7.0 (0.34%)
    Index delayed 20 minutes
  • XAO XAO
    6,821.6
    43.9 (0.65%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 179.1M
  • Value: 154.8M
  • Rise: 120
  • Fall: 46
  • Unch: 663

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.161+0.007
Tritech0.037-0.006
YZJ Shipbldg SGD1.010+0.015
Dyna-Mac0.125+0.007
Golden Agri-Res0.240+0.005
LION-PHILLIP S-REIT1.140+0.003
Mapletree Com Tr2.310+0.020
Citic Envirotech0.535-
GSS Energy0.088+0.006
Spackman0.015+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,506.2 -20.5
HSI 26,621.2 +154.3
HSCEI 10,523.3 +73.0
Jakarta 6,117.4
Nikkei 225 23,204.6 +166.0
SSE Comp 2,913.7 +10.1
Shanghai A 3,052.7 +10.6
Shanghai B 255.1 +0.1
PSE Comp 0.0
KOSPI 2,103.4 +6.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HOMOLOGY MEDICINES INC HOMOLOGY MEDICINES INC
Updated on 21 Nov 2019 (End of trading day)
Last (USD): 14.350 Change: -0.070 High: 14.460 Remarks: -
Change (%): -0.49 Low: 13.890
Open 14.460 Yesterday's Close 14.42
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 193,198 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.29931 Trailing EPS (USD) e -2.24256 NAV (USD) b 5.8549
PE a - Trailing PE f - Price / NAV b 2.4509
Dividend (USD) d - Cash In Hand (USD) g 1.7613 Issued & Paid-up Shares c 44,035,000
Dividend Yield (%) d - Price / Cash In Hand g 8.147 Treasury Shares h 72,577
Beta - 75 Daysi -0.062 R-Squared - 75 Days(%)i 0.02 Market Cap (M) 631.902
Beta - 500 Daysi 0.099 R-Squared - 500 Days (%)i 0.10 Enterprise Value (M) 362.230
Piotroski F Score 2 Exchange Code FIXX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 69.16 Free Float (%) 68.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Nov 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HOMOLOGY MEDICINES INC NASDAQ 631.902 - - 2.4509 -
Industry Biotechnology NASDAQ 2,412.186 142.421 155.214 5.5889 0.723
Local Peer AMGEN INC NASDAQ 135,366.999 16.127 16.780 12.3883 2.456
Local Peer GILEAD SCIENCES INC NASDAQ 83,158.310 15.244 30.879 4.0360 3.515
Local Peer CELGENE CORP NASDAQ 77,035.923 19.040 13.101 6.3735 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,415.825 26.434 25.850 10.5486 -
Local Peer BIOGEN INC NASDAQ 52,050.299 11.748 9.647 3.7190 -
Local Peer ILLUMINA INC NASDAQ 45,988.950 55.677 47.265 10.3602 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 38,514.230 15.756 17.962 3.6665 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,238.003 312.345 16.485 2.3380 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,549.181 - - 11.5471 -
Local Peer INCYTE CORPORATION NASDAQ 19,041.095 173.903 47.019 7.8600 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,843.699 - - 4.5029 -
Local Peer EXACT SCIENCES CORP NASDAQ 11,634.273 - - 15.5481 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), NATERA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CORTEXYME INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGENUS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XBIOTECH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), RETROPHIN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KAMADA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AFFIMED N V (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), SESEN BIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARAVIVE INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), COHBAR INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), INFLARX N V (NASDAQ), VERMILLION INC (NASDAQ), VERASTEM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), EVOGENE LTD (NASDAQ), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TOCAGEN INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), BIOCEPT INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), TROVAGENE INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), OCUGEN INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ)
Global Peer CSL ASX 121,182.756 45.168 45.168 16.1941 0.994
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,231.344 76.681 22.604 5.1046 0.782
Global Peer SINO BIOPHARM HKEx 141,090.750 13.168 13.590 4.1450 0.652
Global Peer WUXI BIO HKEx 117,862.150 157.799 123.364 12.1324 -
Global Peer BEIGENE HKEx 96,573.081 - - 9.6356 -
Global Peer GENSCRIPT BIO HKEx 35,853.548 215.623 - 10.1109 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 31,292.430 20.686 25.178 3.0842 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,705.614 43.152 629.213 2.6141 -
Other Global Peers HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), MYOVANT SCIENCES LTD (NYSE), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), ASCLETIS-B (HKEx), MESOBLAST LTD (ASX), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), LEE'S PHARM (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), NANOVIRICIDES INC (NYSE American), BBI LIFE SCI (HKEx), RESAPP HEALTH LIMITED (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PHYLOGICA LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), BIONOMICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), NOVITA HEALTHCARE LTD (ASX), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ISORAY INC (NYSE American), EXTRAWELL PHAR (HKEx), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), IMMURON LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), IBIO INC (NYSE American), HAO WEN HLDGS (HKEx), MEGASUN (Bursa), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CCP TECHNOLOGIES LTD (ASX), MGRC (Bursa), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AIM IMMUNOTECH INC (NYSE American), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.020
+7.65 %
10 Days -+2.460
+20.69 %
20 Days -+0.920
+6.85 %
Medium Term Return 3 Months --4.370
-23.34 %
6 Months --6.130
-29.93 %
1 Year --5.240
-26.75 %
Annualised Return Annualised --
-26.75 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.050 - 31.800 Change From 1 Year Low +3.300 % Change From 1 Year Low (%) +29.86
Change From 1 Year High -17.450 % Change From 1 Year High (%) -54.87
2 Years Range 11.050 - 31.800 Change From 2 Years Low +3.300 % Change From 2 Years Low (%) +29.86
Change From 2 Years High -17.450 % Change From 2 Years High (%) -54.87
5 Years Range 11.050 - 31.800 Change From 5 Years Low +3.300 % Change From 5 Years Low (%) +29.86
Change From 5 Years High -17.450 % Change From 5 Years High (%) -54.87
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Nov 2019 14.130 14.620 14.040 14.420 349,023 -
19 Nov 2019 13.750 14.520 13.690 14.150 669,672 -
18 Nov 2019 13.480 13.710 13.280 13.670 249,253 -
15 Nov 2019 13.390 13.510 12.900 13.450 209,803 -
14 Nov 2019 12.090 13.545 11.920 13.330 479,668 -
13 Nov 2019 11.470 12.700 11.100 12.090 250,735 -
12 Nov 2019 11.430 11.720 11.230 11.470 114,806 -
11 Nov 2019 11.460 11.710 11.050 11.420 152,087 -
08 Nov 2019 11.870 11.890 11.260 11.450 171,088 -
07 Nov 2019 11.870 12.070 11.550 11.890 179,117 -
06 Nov 2019 12.370 12.505 11.690 11.780 184,593 -
05 Nov 2019 12.610 12.760 12.170 12.380 145,847 -
04 Nov 2019 12.710 12.950 12.460 12.600 305,362 -
01 Nov 2019 13.140 13.286 12.300 12.730 373,201 -
31 Oct 2019 12.820 13.450 12.590 13.130 183,855 -
30 Oct 2019 13.000 13.094 12.430 12.840 423,528 -
29 Oct 2019 12.840 13.400 12.350 12.970 319,659 -
28 Oct 2019 13.310 13.375 12.740 12.820 303,653 -
25 Oct 2019 13.420 13.845 13.120 13.230 137,958 -
24 Oct 2019 13.310 13.495 12.910 13.430 118,064 -
23 Oct 2019 13.710 13.860 13.080 13.190 151,746 -
22 Oct 2019 13.710 13.930 13.300 13.740 108,235 -
Summary
Current 2 Weeks
(07 Nov 2019 to 20 Nov 2019)
11.870 14.620 11.050 14.420 2,825,252 -
Previous 2 Weeks
(24 Oct 2019 to 06 Nov 2019)
13.310 14.620 11.050 11.780 2,495,720 -
4 Weeks from
(26 Sep 2019 to 23 Oct 2019)
19.310 19.510 11.050 13.190 4,079,030 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.